This is comparable to urine 2HG concentrations for gliomas with IDH1/2 mutations (1–14.6 ng/mL), which were found to be much higher than for gliomas with wt IDH1/2 (1–4 ng/mL) (49). This evidence concerns the gene IDH1 and central nervous system cancer.